Continuous Passive Motion Devices Market Size, Share & Trends Analysis Report By Product (Hip Joint, Knee Joint, Shoulder Joint, Ankle Joint), By Applications (Children Below Age 13, Adult, Geriatric), By End Use, By Region, and Segment Forecasts - 2035

Continuous Passive Motion Devices Market Overview

The global continuous passive motion devices market size was valued at USD 639.36 million in 2025 and is projected to grow from USD 664.1 million in 2026 to USD 744.22 million by 2035, at a CAGR of 3.87% from 2026 to 2035.

The continuous passive motion devices market is entering a steady rehabilitation-focused expansion phase as orthopedic surgery volumes, postoperative mobility programs, and home-based recovery models continue to develop across major healthcare systems. In 2026, the market is supported by increasing utilization of controlled-motion rehabilitation following knee replacement, ligament reconstruction, fracture repair, and other orthopedic procedures. Knee joint devices are expected to remain the largest product category, while adult patients account for the broadest demand base. The growing emphasis on early mobility, structured range-of-motion programs, and patient-specific rehabilitation is encouraging healthcare providers to integrate CPM devices into postoperative pathways. Across the forecast period, demand is also being influenced by an aging population, rising musculoskeletal disorders, and the need to reduce prolonged joint stiffness following surgery.

In the USA, continuous passive motion devices remain closely associated with orthopedic rehabilitation, outpatient recovery, home healthcare, and postoperative therapy programs. The country continues to benefit from a large installed base of orthopedic treatment infrastructure, a high concentration of specialized hospitals, and strong adoption of technology-assisted rehabilitation. In 2026, knee-related rehabilitation represents the most commercially important use case, while adult and geriatric patients together account for more than 90% of potential demand within the supplied application structure. The U.S. market is also moving toward more adaptable equipment, easier patient setup, compact designs, and rehabilitation solutions that can support recovery outside conventional hospital environments. These changes are increasing the importance of portability, comfort, adjustability, and simplified operating controls in purchasing decisions.

• 

  Download Free sample to learn more about this report.

Key Findings

• Leading Product Type: Knee Joint devices are expected to hold the largest share at approximately 54.2% in 2026, supported by high utilization after knee replacement and ligament procedures and their established role in structured postoperative range-of-motion programs.
• Leading Application: Adult patients are expected to represent about 63.7% of demand in 2026, reflecting the large volume of orthopedic procedures performed among working-age and older adult populations requiring controlled rehabilitation.
• Leading Region: North America is projected to lead with nearly 38.6% market share in 2026, supported by advanced orthopedic infrastructure, established reimbursement pathways, and widespread access to postoperative rehabilitation services.
• Fastest Growing Region: Asia-Pacific is projected to record the fastest regional expansion, with annual market development expected around 5.1% during the forecast period as orthopedic treatment capacity and rehabilitation access expand.
• Technology Trend: Compact and patient-adjustable CPM systems are gaining importance, with portable rehabilitation solutions expected to account for more than 40% of new purchasing interest as home-based recovery programs expand.
• Market Driver: Rising orthopedic surgery volumes remain a primary growth factor, with knee replacement and related rehabilitation procedures representing more than 50% of demand associated with continuous passive motion applications.
• Competitive Landscape: Product development is increasingly focused on easier patient fitting and broader rehabilitation workflows, illustrated by recent device enhancements that can accommodate multiple leg dimensions without repeated manual measurement.
• Future Outlook: The market is expected to move toward connected and personalized rehabilitation, with digital monitoring and individualized motion protocols potentially influencing more than 25% of newly developed CPM platforms by 2035.

Latest Trends

The continuous passive motion devices market is increasingly shaped by the transition from conventional hospital-centered rehabilitation toward flexible postoperative care models. In 2026, healthcare providers are placing greater emphasis on patient mobility during the first several days and weeks following orthopedic procedures, creating demand for equipment that can provide repeatable movement without requiring continuous therapist intervention. Knee Joint devices remain central to this trend because knee replacement, ligament reconstruction, and related procedures generate substantial rehabilitation requirements. Manufacturers are also improving frame adjustability, support structures, operating controls, and patient positioning so that devices can accommodate different body sizes with fewer setup changes. This development is particularly relevant for home-based recovery, where patients may have limited assistance and need straightforward operating procedures.

Personalization is another important trend influencing product development. CPM systems are increasingly expected to support controlled movement ranges, adjustable speed settings, and patient-specific positioning rather than relying on one standardized operating configuration. Recent rehabilitation technology research has also demonstrated growing interest in robotic and sensor-assisted passive motion systems, including shoulder rehabilitation concepts using 6 degrees of freedom and motion replication accuracy below 1 degree. Although these advanced systems remain distinct from mainstream CPM equipment, their development indicates the direction of future rehabilitation engineering. Over the next 9 years, manufacturers are likely to prioritize compact electronics, quieter motors, improved mechanical alignment, simplified controls, and data-enabled therapy monitoring while maintaining the basic requirement of safe and repeatable passive movement.

Market Dynamics

Driver

""Increasing orthopedic rehabilitation demand is strengthening continuous passive motion adoption across 2026–2035.""

The strongest market driver is the increasing number of orthopedic interventions that require structured postoperative mobility programs. Knee replacement, ligament reconstruction, fracture stabilization, and other joint procedures can create periods of restricted movement during early recovery. CPM equipment provides controlled repetitive movement during these periods and therefore remains relevant within selected rehabilitation protocols. In 2026, Knee Joint devices are estimated to represent about 54.2% of the market, demonstrating the strong relationship between knee-related procedures and CPM demand.

Population aging is adding another layer of demand. The geriatric population experiences a higher incidence of osteoarthritis, joint degeneration, reduced mobility, and postoperative recovery requirements than younger groups. Within the supplied application segmentation, Geriatric patients are estimated to represent approximately 28.4% of market demand in 2026. This share gives manufacturers an incentive to develop equipment with easier positioning, improved support, lower operating complexity, and greater comfort for patients who may have limited strength or mobility.

Healthcare providers are also increasingly interested in shortening unnecessary inpatient rehabilitation periods while maintaining structured recovery. CPM systems can support repeated movement sessions without requiring a therapist to manually perform every motion cycle. This creates operational value in hospitals, rehabilitation centers, and home-care settings. As outpatient orthopedic procedures continue to increase, the need for equipment that can be transported and used under supervised or semi-supervised conditions is expected to strengthen. By 2030, portable and compact configurations could represent more than 45% of purchasing preferences in selected developed markets.

Restraint

""Clinical protocol variation and competing rehabilitation approaches can limit uniform CPM utilization.""

A major restraint is the variation in clinical protocols governing the use of continuous passive motion devices. Physicians, physical therapists, hospitals, and rehabilitation centers may differ in how frequently CPM equipment is prescribed and which patients are considered suitable candidates. Some postoperative pathways place greater emphasis on active physiotherapy, assisted exercises, walking programs, and therapist-guided movement. This variation can reduce the consistency of CPM adoption across hospitals and countries. In 2026, this remains particularly relevant because purchasing decisions depend not only on device performance but also on institutional rehabilitation policies.

Device cost, maintenance requirements, storage space, and patient training can also influence purchasing decisions. A CPM system used in a hospital may require cleaning procedures, regular inspection, replacement components, and staff training. Home deployment creates additional requirements involving transportation, patient instruction, device fitting, and technical support. For smaller rehabilitation centers serving fewer than 50 patients per month, these operational considerations can make purchasing decisions more cautious than those of large orthopedic hospitals.

Another restraint is the availability of alternative rehabilitation methods. Manual physiotherapy, active-assisted exercises, stationary rehabilitation equipment, and other therapeutic approaches can compete for clinical budgets. Healthcare providers increasingly evaluate equipment according to measurable patient outcomes, utilization rates, therapist productivity, and total operating costs. Consequently, CPM manufacturers must demonstrate practical benefits rather than relying only on the traditional role of passive movement. This pressure is likely to remain important through 2035, particularly in markets where healthcare procurement is strongly focused on cost-effectiveness.

Opportunity

""Home rehabilitation, personalization, and digital monitoring create new opportunities for CPM manufacturers.""

The expansion of home-based orthopedic recovery represents one of the strongest opportunities for continuous passive motion device suppliers. Patients increasingly seek rehabilitation options that allow recovery to continue outside hospitals and rehabilitation facilities. Compact CPM equipment can support this transition when prescribed and monitored appropriately. In 2026, portable rehabilitation solutions are estimated to account for more than 40% of new market interest, indicating the commercial importance of lightweight construction, easier transportation, and simplified setup.

Digital connectivity creates another opportunity. Manufacturers can integrate usage timers, programmable motion settings, treatment-session records, and remote monitoring capabilities into future systems. These features can allow clinicians to understand whether patients are following prescribed rehabilitation schedules. A device capable of recording 5 to 10 therapy parameters per session could provide more useful information than a conventional system that only performs mechanical movement. Over the next several years, connected rehabilitation platforms could therefore become increasingly important for hospitals seeking continuity between inpatient treatment, outpatient therapy, and home recovery.

Emerging healthcare markets provide an additional expansion opportunity. Countries across Asia-Pacific, Latin America, and selected Middle Eastern markets are increasing orthopedic treatment capacity and developing specialized rehabilitation services. As access to joint replacement and trauma care improves, the supporting rehabilitation infrastructure must also expand. Asia-Pacific is expected to be the fastest-growing regional market, with annual development around 5.1% during the forecast period. Manufacturers able to offer reliable equipment, localized service, competitive maintenance programs, and training support can strengthen their position in these markets.

Challenge

""Manufacturers must balance clinical performance, affordability, portability, and regulatory requirements.""

The market faces a continuing challenge in balancing advanced functionality with affordability. Healthcare providers want devices that deliver accurate and repeatable movement while remaining easy to operate and maintain. Adding sensors, digital displays, programmable controls, connectivity, and automated adjustment can improve functionality but may increase product complexity. Manufacturers therefore need to determine which features provide measurable value. A product that adds 5 advanced functions but significantly increases training requirements may not be preferred over a simpler system with reliable core performance.

Regulatory compliance and quality assurance also remain important challenges. Medical rehabilitation equipment must meet applicable safety, electrical, mechanical, and clinical requirements in each target market. Manufacturers operating across 20 or more countries may need to manage multiple regulatory pathways, labeling requirements, technical documentation standards, and post-market obligations. These requirements can lengthen product development timelines and increase the resources needed to commercialize new equipment.

Supply-chain resilience is another concern. CPM devices contain motors, mechanical components, electronic controls, structural materials, padding, fasteners, and other parts that must meet consistent quality requirements. Disruption affecting even 1 critical component can delay final assembly and product delivery. Companies therefore need multiple qualified suppliers, inventory planning, and quality-control systems. Between 2026 and 2035, manufacturers that combine robust sourcing with modular product architecture are likely to be better positioned to manage supply risks while maintaining consistent product availability.

• 

  Download Free sample to learn more about this report.

Segmentation Analysis

By Types

Knee Joint: Knee Joint CPM devices are expected to remain the dominant product segment, accounting for approximately 54.2% of the global market in 2026. Their leading position is supported by extensive use in postoperative knee rehabilitation, particularly after knee replacement, ligament reconstruction, and other procedures requiring controlled range-of-motion recovery. The segment is expected to retain its leadership through 2035 as the adult and geriatric populations continue to generate substantial orthopedic rehabilitation demand. Product development is increasingly focused on adjustable leg supports, smoother movement, compact frames, and simplified controls. In high-volume orthopedic centers, devices capable of supporting repeated therapy sessions across 8 to 12 hours can improve equipment utilization and strengthen purchasing justification.

Shoulder Joint: Shoulder Joint CPM devices are estimated to hold approximately 18.6% market share in 2026, making them the second-largest supplied product category. Demand is supported by shoulder reconstruction, postoperative stiffness management, and rehabilitation following selected surgical interventions. Shoulder movement is mechanically complex, which increases the importance of accurate positioning and controlled motion. Manufacturers are therefore emphasizing adjustable support and anatomically appropriate movement paths. Advanced rehabilitation research involving 6-degree-of-freedom shoulder systems demonstrates the broader engineering direction toward personalized movement control. Between 2026 and 2035, shoulder-focused systems are expected to benefit from greater attention to motion precision, patient comfort, and therapist-controlled treatment parameters.

Hip Joint: Hip Joint CPM devices are expected to represent around 15.4% of the market in 2026. The segment is supported by hip-related orthopedic procedures, postoperative mobility management, and rehabilitation needs among older adults. Hip rehabilitation can require careful positioning because patient mobility may be restricted during the initial recovery phase. Product demand is therefore influenced by ergonomic supports, adjustable movement ranges, and easy patient transfer. The segment is also linked to demographic aging, with geriatric patients accounting for approximately 28.4% of the application market. Through 2035, hip rehabilitation equipment is expected to benefit from increasing orthopedic procedure volumes and the expansion of rehabilitation infrastructure in developing healthcare markets.

Ankle Joint: Ankle Joint CPM devices are projected to account for approximately 11.8% market share in 2026. Demand is generated by selected trauma, reconstructive, and postoperative rehabilitation applications where controlled ankle movement can be incorporated into a broader therapy program. The segment remains smaller than knee, shoulder, and hip devices because the addressable procedure base is narrower. However, sports injuries, fracture-related rehabilitation, and increasing interest in early controlled movement provide opportunities for growth. Manufacturers are focusing on adjustable positioning and compact structures because ankle rehabilitation equipment must accommodate different lower-limb geometries. From 2026 to 2035, the segment is expected to gain incremental demand as specialized orthopedic and sports medicine services expand.

By Applications

Children Below Age 13: Children Below Age 13 are expected to account for approximately 7.9% of continuous passive motion device demand in 2026. The smaller share reflects the narrower volume of pediatric procedures requiring CPM therapy compared with adult orthopedic rehabilitation. Pediatric equipment must provide appropriate positioning, movement limits, and physical support for younger patients. Adjustable structures are particularly important because patient dimensions can vary significantly across the under-13 age range. Manufacturers that offer flexible fitting across multiple pediatric body sizes can address more clinical use cases without requiring separate equipment for every age group. Pediatric rehabilitation centers and specialized hospitals remain important demand points for this segment.

Adult: Adult patients represent the largest application segment, with an estimated 63.7% market share in 2026. The segment benefits from high orthopedic procedure volumes among working-age and older adults, including knee, shoulder, hip, and ankle interventions. Adults also represent the broadest potential patient population for home-based postoperative rehabilitation. Device requirements increasingly include simple controls, adjustable movement parameters, comfortable supports, and operating durations compatible with individualized treatment schedules. With adults accounting for nearly two-thirds of market demand, manufacturers are likely to continue prioritizing universal-fit designs and adaptable systems capable of serving different body sizes and rehabilitation protocols.

Geriatric: Geriatric patients are expected to represent approximately 28.4% of market demand in 2026, making this the second-largest supplied application segment. Aging increases the incidence of osteoarthritis, joint replacement, reduced mobility, and postoperative rehabilitation requirements. Older patients may also require equipment that minimizes setup complexity and provides stable limb support during treatment. Product designs emphasizing easy controls, clear displays, secure positioning, and comfortable padding can improve usability for this population. Between 2026 and 2035, the geriatric segment is expected to remain strategically important as healthcare systems respond to increasing demand for orthopedic care and mobility preservation among older populations.

• 

  Download Free sampleto learn more about this report.

Regional Outlook

North America

North America is expected to remain the leading regional market, accounting for approximately 38.6% of global demand in 2026. The region benefits from advanced orthopedic infrastructure, established rehabilitation services, high levels of healthcare technology adoption, and a strong concentration of specialized medical facilities. The United States represents the largest national market within the region, supported by extensive knee and shoulder procedures and a mature network of orthopedic surgeons, physical therapists, rehabilitation centers, and home-care providers. Knee Joint devices remain particularly important because postoperative knee rehabilitation creates a large recurring application base.

The regional market is also moving toward more flexible rehabilitation models. In 2026, home-based treatment, outpatient surgery, and ambulatory care are increasingly influencing equipment procurement decisions. Manufacturers are responding with lighter systems, adjustable supports, and easier controls that can be used across multiple patient settings. Adult patients account for the largest demand share, while geriatric orthopedic care provides another substantial opportunity. Over the 2026–2035 period, North American demand is expected to remain stable as providers continue investing in technologies that support structured recovery and efficient postoperative care.

Europe

Europe is projected to account for approximately 27.4% of the global continuous passive motion devices market in 2026. The region benefits from established healthcare systems, large populations requiring orthopedic care, and strong rehabilitation infrastructure across countries such as Germany, France, the United Kingdom, Italy, and Spain. Aging demographics are particularly important because older adults have greater exposure to joint degeneration and postoperative mobility limitations. Knee and hip rehabilitation therefore remain major demand contributors. Hospitals and rehabilitation centers increasingly evaluate devices according to clinical utility, patient comfort, maintenance requirements, and lifecycle performance.

European procurement is also influenced by healthcare efficiency and product sustainability. Manufacturers are increasingly expected to provide durable equipment, reliable replacement components, service support, and clear technical documentation. Portable systems can benefit from the expansion of outpatient rehabilitation and home recovery programs. By 2030, demand for flexible equipment capable of supporting both clinical and home settings is expected to increase. The region's mature regulatory environment may lengthen product development cycles, but companies with established compliance systems and strong clinical support capabilities can maintain durable positions across the European market.

Asia-Pacific

Asia-Pacific is expected to represent approximately 23.1% of global demand in 2026 and is projected to record the fastest regional growth at around 5.1% annually through the forecast period. China, Japan, India, South Korea, and Australia represent important demand centers because of their expanding orthopedic treatment capacity and diverse aging profiles. Japan has a particularly strong geriatric care requirement, while China and India offer substantial long-term opportunities due to large patient populations and increasing healthcare investment. Knee Joint equipment is expected to remain the most commercially important product category across many Asia-Pacific markets.

Healthcare modernization is creating additional opportunities in the region. Hospitals are upgrading orthopedic departments, rehabilitation facilities are expanding specialized services, and patients are gaining greater access to postoperative care. However, purchasing priorities vary significantly between developed and emerging economies. Premium systems may be preferred in Japan and Australia, while price-performance balance is likely to be more important in India and other developing markets. Manufacturers offering scalable products, local technical support, multilingual training, and flexible distribution models can strengthen market penetration between 2026 and 2035.

Latin America

Latin America is estimated to account for approximately 6.2% of global continuous passive motion device demand in 2026. The market is supported by growing orthopedic treatment access, increasing awareness of rehabilitation, and gradual expansion of private healthcare infrastructure. Brazil and Mexico represent important demand centers because of their relatively large healthcare markets and developing orthopedic service networks. Knee rehabilitation is expected to represent the largest application area within the region, followed by shoulder and hip rehabilitation. Adult patients remain the primary demand group because of the broad number of orthopedic procedures performed across private and public facilities.

Cost sensitivity remains a major factor in purchasing decisions across Latin America. Healthcare providers often evaluate equipment based on acquisition cost, service availability, spare-parts access, and expected operating life. This creates opportunities for manufacturers that can provide reliable systems with limited maintenance requirements. Distribution partnerships can also play an important role because regional healthcare markets differ in regulatory processes and purchasing structures. Between 2026 and 2035, broader rehabilitation awareness and increasing orthopedic procedure volumes are expected to support gradual market development, particularly in countries investing in specialized postoperative services.

Middle East & Africa

The Middle East & Africa region is expected to represent approximately 4.7% of global demand in 2026. Market development is supported by increasing healthcare infrastructure investment, modernization of hospitals, private healthcare expansion, and the gradual development of specialized orthopedic and rehabilitation services. Gulf countries are expected to represent important purchasing centers because of their investment in advanced healthcare facilities and medical technologies. Adult and geriatric patients provide the largest demand opportunities, while knee rehabilitation is expected to remain the most commercially significant product application.

Market development across Africa remains more uneven because healthcare infrastructure, medical equipment access, reimbursement structures, and rehabilitation capacity vary substantially between countries. Nevertheless, urban healthcare centers and private hospitals are gradually expanding orthopedic services. Manufacturers can improve penetration by offering durable products, localized training, service agreements, and straightforward operating systems. Equipment that can withstand intensive institutional use while remaining easy to maintain is particularly relevant. From 2026 through 2035, the region is expected to grow from a smaller base as specialized rehabilitation facilities and orthopedic treatment capacity expand.

Companies

DJO Global, Inc. (U.S.A.): DJO Global, Inc. remains an important participant in orthopedic rehabilitation and continuous passive motion equipment through its broader rehabilitation portfolio. The company has continued emphasizing patient-focused orthopedic recovery technologies, with product development increasingly addressing fitting flexibility and ease of use. A notable recent development was the U.S. commercial launch of the Slingshot CPM 3 knee continuous passive motion device in September 2024, featuring an adjustable leg cradle designed to accommodate a broad clinical range without repeated measurement during setup. This type of product development demonstrates the market's movement toward simplified fitting and greater usability.

Stryker Corporation (U.S.A.): Stryker maintains a strong position in orthopedic and sports medicine technologies, providing a broad ecosystem surrounding surgical intervention and postoperative rehabilitation. Its orthopedic portfolio gives the company exposure to procedures that generate demand for controlled rehabilitation. In 2026, Stryker continued updating medical technology platforms and supporting product lifecycle management, reflecting the importance of software, equipment reliability, and long-term service. Its broader sports medicine portfolio also demonstrates continuing emphasis on early recovery, passive movement, and rehabilitation pathways. The company is positioned to benefit from increasing orthopedic procedure volumes and the integration of rehabilitation into broader musculoskeletal care.

Zimmer Biomet Holdings, Inc. (U.S.A.): Zimmer Biomet has a significant presence in orthopedics, particularly in hip and knee procedures that directly influence rehabilitation demand. Its strategic focus on orthopedic technology, robotics, and patient outcomes creates opportunities to connect surgical innovation with postoperative recovery. In January 2026, the company launched the Brachiator Mini-Rail External Fixation System for complex foot and ankle reconstruction, illustrating continued development in lower-extremity orthopedic care. In 2025, Zimmer Biomet also announced an approximately USD 177 million acquisition of Monogram Technologies to strengthen its surgical robotics capabilities, highlighting the broader technological direction of orthopedic care.

Breg, Inc. (U.S.A.): Breg, Inc. is an established participant in orthopedic rehabilitation and bracing solutions, with market positioning supported by products designed around postoperative care and mobility management. The company operates within a competitive environment where clinicians increasingly seek equipment that is simple to fit, comfortable for patients, and compatible with established therapy workflows. Breg's opportunity in CPM devices is strengthened by its relationships with orthopedic providers and rehabilitation professionals. As home-based recovery expands, the ability to support patient education, device fitting, and service responsiveness will remain important competitive factors through 2035.

Össur hf. (Iceland): Össur hf. participates in the broader rehabilitation and mobility technology ecosystem, with expertise spanning orthopedic support, prosthetics, and patient rehabilitation. Its rehabilitation-oriented capabilities provide a foundation for addressing patients requiring structured mobility recovery. In June 2026, Össur continued supporting upper-limb rehabilitation education through a 2-day professional training program covering assessment, clinical decision-making, rehabilitation techniques, and functional participation. Although not limited to CPM devices, this activity illustrates the growing importance of clinician education and integrated rehabilitation expertise in the competitive medical technology environment.

Top 2 Companies Market Share

DJO Global, Inc. (U.S.A.): DJO Global, Inc. is estimated to hold approximately 14.8% of the global continuous passive motion devices market in 2026 among the supplied leading companies. Its position is supported by established orthopedic rehabilitation expertise, a broad clinical network, and continuing development of CPM solutions. The 2024 launch of the Slingshot CPM 3 strengthened the company's positioning in knee rehabilitation by addressing adjustability and fitting efficiency. Its competitive strategy is increasingly aligned with patient convenience, clinical workflow efficiency, and rehabilitation equipment usability.

Stryker Corporation (U.S.A.): Stryker Corporation is estimated to account for approximately 12.9% of the market in 2026 among the supplied leading companies. Its strength comes from a broad orthopedic and sports medicine ecosystem and relationships with hospitals and surgical specialists. The company's continuing investment in orthopedic technologies supports exposure to procedures requiring postoperative rehabilitation. Stryker's emphasis on product lifecycle support and technology integration is also relevant as healthcare providers increasingly expect medical equipment to remain serviceable and compatible with evolving clinical workflows through multi-year purchasing cycles.

Investment Analysis

Investment opportunities in the continuous passive motion devices market are concentrated around product modernization, portability, home rehabilitation, and patient-specific functionality. The market's projected expansion from USD 664.1 million in 2026 to USD 744.22 million by 2035 indicates a steady demand environment rather than a short-term high-growth cycle. Investors and manufacturers can therefore benefit from strategies emphasizing recurring institutional demand, durable product platforms, replacement cycles, service contracts, and geographic expansion. Knee Joint devices should remain a major investment priority because their estimated 54.2% share gives them the largest addressable segment within the supplied product structure.

Investment can also be directed toward emerging regional markets where rehabilitation infrastructure is still developing. Asia-Pacific is expected to grow at approximately 5.1% annually, creating opportunities for distributors, local manufacturing partnerships, technical service networks, and training programs. Home-care equipment is another attractive area because portable solutions can expand the addressable customer base beyond hospitals. Companies that reduce product weight, simplify patient setup, improve cleaning procedures, and incorporate programmable treatment settings can potentially differentiate themselves in procurement processes. Between 2026 and 2035, investments combining mechanical reliability with digital functionality are likely to have stronger strategic relevance than investments focused only on incremental hardware changes.

New Product Development

New product development is increasingly centered on improving patient fit, movement accuracy, portability, and ease of operation. The next generation of CPM systems is expected to use more adjustable mechanical structures, quieter drive systems, improved padding, and intuitive controls. Product designers are also examining ways to reduce setup time from several minutes to shorter standardized procedures. The 2024 introduction of the Slingshot CPM 3, which incorporated an adjustable leg cradle accommodating different patient dimensions without repeated clinical measurement, illustrates the commercial value of this design direction. Similar principles can be applied across knee, shoulder, hip, and ankle configurations.

Digital functionality represents another major product development opportunity through 2035. Future systems can incorporate programmable therapy sessions, motion-range presets, usage tracking, electronic safety controls, and remote data transfer. Advanced rehabilitation research is already demonstrating highly precise passive movement concepts, including systems capable of reproducing shoulder movement patterns with errors below 1 degree. Mainstream CPM manufacturers can adapt selected principles from this research without making devices excessively complex. Development programs are therefore likely to prioritize practical digital features that improve therapy consistency while keeping controls understandable for patients and clinicians. Products that can operate reliably for 8 to 12 hours per day may also gain preference in intensive rehabilitation environments.

Five Recent Developments

• September 2024: DJO Global introduced the Slingshot CPM 3 knee continuous passive motion device in the U.S. market, incorporating an adjustable leg cradle designed to accommodate a broad range of patient leg lengths and circumferences while reducing repeated setup measurement requirements.
• July 2025: Zimmer Biomet announced an agreement to acquire Monogram Technologies for approximately USD 177 million, strengthening its surgical robotics capabilities and expanding technology exposure around knee procedures and advanced orthopedic workflows.
• August 2025: Zimmer Biomet reported stronger-than-expected demand for hip and knee orthopedic products, with the hips and knees business reaching USD 1.36 billion in the second quarter, reinforcing the broader procedure environment supporting postoperative rehabilitation demand.
• January 2026: Zimmer Biomet launched the Brachiator Mini-Rail External Fixation System for foot and ankle reconstruction, demonstrating continued innovation in lower-extremity orthopedic care and strengthening the technology ecosystem surrounding ankle rehabilitation applications.
• June 2026: Össur continued expanding professional rehabilitation education through a 2-day upper-limb occupational therapy program covering assessment, clinical decision-making, rehabilitation techniques, and functional participation, highlighting the growing role of clinician training in advanced mobility care.

Report Coverage

The continuous passive motion devices market assessment covers the global industry outlook for 2026–2035, with analysis structured around Hip Joint, Knee Joint, Shoulder Joint, and Ankle Joint product categories and Children Below Age 13, Adult, and Geriatric applications. The assessment evaluates market dynamics, product positioning, application demand, regional development, technology trends, investment opportunities, product innovation, and competitive strategies. The market baseline indicates USD 664.1 million in 2026 and USD 744.22 million by 2035, corresponding to a 3.87% CAGR across the forecast period.

The geographic assessment covers North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, with particular attention to orthopedic infrastructure, rehabilitation access, demographic trends, healthcare modernization, and purchasing priorities. Competitive coverage includes DJO Global, Inc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Breg, Inc., and Össur hf. The analysis also evaluates developments from 2024 through 2026, including product launches, orthopedic technology expansion, rehabilitation education, and changing demand for portable and patient-adjustable equipment. The report is designed to support strategic planning, product development, market entry, investment assessment, and competitive positioning through 2035.